Afaf Merza Mohamed
Overview
Explore the profile of Afaf Merza Mohamed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
18
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matar E, Mohamed A, Ali G, Ali F, Husain M, Moosa A, et al.
Cureus
. 2025 Jan;
16(12):e76551.
PMID: 39877782
Introduction: Mumps is a vaccine-preventable disease caused by the paramyxovirus affecting the salivary gland and may be complicated by orchitis, oophoritis, and encephalitis. This study aims to describe the epidemiology,...
2.
Sayyad A, Mohamed A, Alajaimi B, Matar E, Hasan W, Aldolabi Q, et al.
Qatar Med J
. 2024 Jul;
2024(3):28.
PMID: 38974774
Background: Severe acute respiratory tract infections (SARI) pose a health threat to children and adults worldwide. The SARI surveillance program was initiated in 2018 in Bahrain to monitor the activity...
3.
Mohamed A, Matar E, Isa H, Moosa A, Hasan W, Mohamed A, et al.
Influenza Other Respir Viruses
. 2023 Nov;
17(11):e13194.
PMID: 37964990
Background: Several countries, including Bahrain, used wastewater surveillance for disease activity monitoring. This study aimed to determine the presence of SARS-CoV-2 in untreated wastewater and to correlate it with the...
4.
Mohamed A, Sayyad A, Matar E, Isa H, Hasan W, Hashim N, et al.
Influenza Other Respir Viruses
. 2023 May;
17(4):e13133.
PMID: 37123813
Background: Severe acute respiratory tract infection (SARI) is a major global health threat. This study aimed to examine risk factors associated with poor outcomes in patients with SARI. Methods: All...
5.
Mallah S, AlAwadhi A, Jawad J, Wasif P, Alsaffar B, Alalawi E, et al.
Vaccine
. 2023 Feb;
41(12):1925-1933.
PMID: 36725431
Background: Booster vaccine doses against SARS-CoV-2 have been advocated to address evidence of waning immunity, breakthrough infection, and the emergence of immune-evasive variants. A heterologous prime-boost vaccine strategy may offer...
6.
Koch E, Du J, Dressner M, Alwasti H, Al Taif Z, Shehab F, et al.
medRxiv
. 2022 Aug;
PMID: 36032980
A multitude of demographic, health, and genetic factors are associated with the risk of developing severe COVID-19 following infection by the SARS-CoV-2. There is a need to perform studies across...
7.
Mohamed A, Isa H, Ali M, Dadi A, Kadhim Z
Oman Med J
. 2022 Mar;
37(2):e350.
PMID: 35356372
Objectives: To identify the prevalence of non-alcoholic fatty liver disease (NAFLD) among patients with type 2 diabetes mellitus (T2DM) in Bahrain and to assess the risk factors for the same....